August 15th, 2022Transit Scientific achieved increased U.S. patent protection for their novel exoskeleton focal-force angioplasty technology using standard off-the-shelf peripheral transluminal angioplasty (PTA) balloons.
Park City, Utah USA, August 15, 2022. Transit Scientific, a Utah-based medical device company, today announced additional U.S. patent...
June 27th, 2022Transit Scientific achieved increased U.S. patent protection for their novel exoskeleton focal-force angioplasty technology using standard off-the-shelf peripheral transluminal angioplasty (PTA) balloons.
Park City, Utah USA, June 27, 2022. Transit Scientific, a Utah-based medical device company, today announced newly issued U.S. patent...
